There are 2867 resources available
1506P - Role of 18F-FDG PET/CT in the initial staging of very high risk Ewing sarcoma in a prospective multicentric phase II study: Is there still a place for bone marrow sampling?
Presenter: Nina Jehanno
Session: Poster session 11
1095P - Concomitant genetic alterations predicted response to alectinib in patients with ALK-rearranged non-small cell lung cancer: A real word study in China
Presenter: Xueqin Chen
Session: Poster session 15
823P - A propensity score weighted comparison of tebentafusp or pembrolizumab versus combination ipilimumab and nivolumab in untreated metastatic uveal melanoma
Presenter: Josep Maria Piulats Rodriguez
Session: Poster session 03
1507P - Distinct enomic features between osteosarcomas initially metastasing to bone and to lung
Presenter: Lu Xie
Session: Poster session 11
1096P - Identifying predictive biomarkers for long term response on immunotherapy in non-small cell lung cancer (NSCLC)
Presenter: Lore Decoster
Session: Poster session 15
824P - Patterns of response/progression and management following progressive disease (PD) with anti-PD-(L)1 (PD(L)1) in patients (pts) with advanced Merkel cell carcinoma (MCC)
Presenter: Jeremy Mo
Session: Poster session 03
1508P - Pre-treatment high serum alkaline phosphatase level as a prognostic factor for patients with localized extremity osteosarcoma: A retrospective analysis of adolescent and adult patients
Presenter: Ayse Durnali
Session: Poster session 11
1097P - Impact of tumor and liquid rebiopsy in metastatic non-small cell lung cancer with EGFR/ALK/ROS oncogenic drivers, progressing after optimal target therapy
Presenter: Antoine BRONSTEIN
Session: Poster session 15
825P - CemiplimAb-rwlc Survivorship and Epidemiology (CASE): A prospective study of the safety and efficacy of cemiplimab in patients (pts) with advanced cutaneous squamous cell carcinoma (CSCC) in a real-world setting
Presenter: Guilherme Rabinowits
Session: Poster session 03
1509P - Efficacy and safety of vimseltinib in tenosynovial giant cell tumour (TGCT): Phase II expansion
Presenter: Jean-Yves Blay
Session: Poster session 11